Eli Lilly & Co. | Ownership
Companies that own Eli Lilly & Co.
The Vanguard Group, Inc.
72,156,616
6.72%
692,615
0.25%
06/30/2018
Wellington Management Co. LLP
55,254,415
5.15%
-319,723
1.09%
06/30/2018
PRIMECAP Management Co.
55,102,514
5.13%
555,731
3.94%
06/30/2018
BlackRock Fund Advisors
46,364,703
4.32%
-1,671,887
0.24%
06/30/2018
SSgA Funds Management, Inc.
39,073,662
3.64%
-444,163
0.31%
06/30/2018
Dodge & Cox
27,020,471
2.52%
5,178,354
1.5%
06/30/2018
State Farm Investment Management Corp.
19,944,525
1.86%
0
2.6%
06/30/2018
Franklin Mutual Advisers LLC
16,010,981
1.49%
540,801
3.37%
06/30/2018
Geode Capital Management LLC
11,729,680
1.09%
1,229,984
0.31%
06/30/2018
Northern Trust Investments, Inc.
11,305,909
1.05%
3,412
0.27%
06/30/2018
| Address |
Lilly Corporate Center
Indianapolis Indiana 46285
United States
|
|
Employees
|
- |
| Website |
http://www.lilly.com |
| Updated |
07/08/2019 |
| Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through two segments: Human Pharmaceutical Products and Animal Health. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. |
